文献速递分子诊断临床微生物

感染性疾病分子诊断四十年

Forty Years of Molecular Diagnostics for Infectious Diseases.
PubMed 文献 · J Clin Microbiol · 2022-07-19

本文综述了PCR发明近40年来临床微生物分子诊断技术的发展与现状。自COVID-19大流行以来,分子诊断在全球感染性疾病诊疗中作用显著提升。文章涵盖核酸检测、定量及序列特征分析,并从技术、病理生理、临床/实验室后勤及财务/监管多维度综合评述。

要点

  • 分子诊断已从单纯检测扩展到核酸定量与序列分析。
  • COVID-19大流行加速了分子诊断的全球应用与普及。
  • 技术发展受病理生理知识、临床 logistics 及财务监管共同塑造。

核心结论

  • 分子诊断技术已深度融入临床微生物学,并在全球医疗中占据重要地位。

研究设计与样本

  • 综述类文章,回顾近40年临床微生物分子诊断技术进展。

主要发现

  • 分子方法现已涵盖微生物核酸检测、定量及基于序列的特征分析。
  • COVID-19大流行期间分子诊断的全球作用超过以往任何时期。

临床怎么用

  • 检验科应关注分子诊断在检测、定量和序列分析方面的综合应用。
  • 需综合考量技术革新、病理生理知识、临床与实验室流程及财务监管因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Nearly 40 years have elapsed since the invention of the PCR, with its extremely sensitive and specific ability to detect nucleic acids via in vitro enzyme-mediated amplification. In turn, more than 2 years have passed since the onset of the coronavirus disease 2019 (COVID-19) pandemic, during which time molecular diagnostics for infectious diseases have assumed a larger global role than ever before. In this context, we review broadly the progression of molecular techniques in clinical microbiology, to their current prominence. Notably, these methods now entail both the detection and quantification of microbial nucleic acids, along with their sequence-based characterization. Overall, we seek to provide a combined perspective on the techniques themselves, as well as how they have come to shape health care at the intersection of technologic innovation, pathophysiologic knowledge, clinical/laboratory logistics, and even financial/regulatory factors.

来源:J Clin Microbiol,查看原文。版权归原作者所有。

引用

  1. Schmitz JE, Stratton CW, Persing DH, et al. Forty Years of Molecular Diagnostics for Infectious Diseases. J Clin Microbiol. 2022. PMID: 35852340. doi:10.1128/jcm.02446-21

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。